Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection

Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection

Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in children and the elderly. However, there are no effective antiviral drugs or licensed vaccines available for RSV infection. Here, RSV virus-like particle (VLP) vaccines expressing Pre-F, G, or Pre-F and G proteins on...

Full description

Bibliographic Details
Main Authors: Su-Hwa Lee, Ki-Back Chu, Min-Ju Kim, Jie Mao, Gi-Deok Eom, Keon-Woong Yoon, Md Atique Ahmed, Fu-Shi Quan
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
respiratory syncytial virus
virus-like particle
pre-fusion
glycoprotein
vaccine
Online Access:https://www.mdpi.com/1999-4923/15/3/782

Similar Items

Similar Items